A novel sensor based on nanobiocomposite Au-­In2O3-­chitosan modified acetylene black paste electrode for sensitive detection of antimycotic ciclopirox olamine

Chitosan-Based Electrochemical Sensors for Pharmaceuticals and Clinical Applications

Chitosan (CTS), a biocompatible and multifunctional material derived from chitin, has caught researchers' attention in electrochemical detection due to its unique properties. This review paper provides a comprehensive overview of the recent progress and applications of CTS-based electrochemical sensors in the analysis of pharmaceutical products and other types of samples, with a particular focus on the detection of medicinal substances. The review covers studies and developments from 2003 to 2023, highlighting the remarkable properties of CTS, such as biocompatibility, chemical versatility, and large surface area, that make it an excellent candidate for sensor modification. Combining CTS with various nanomaterials significantly enhances the detection capabilities of electrochemical sensors. Various types of CTS-based sensors are analyzed, including those utilizing carbon nanomaterials, metallic nanoparticles, conducting polymers, and molecularly imprinted CTS. These sensors exhibit excellent sensitivity, selectivity, and stability, enabling the precise and reliable detection of medications. The manufacturing strategies used for the preparation of CTS-based sensors are described, the underlying detection mechanisms are elucidated, and the integration of CTS sensors with transducer systems is highlighted. The prospects of CTS-based electrochemical sensors are promising, with opportunities for miniaturization, simultaneous detection, and real-time monitoring applications.

Synergistic effect of gold nanoparticles anchored on conductive carbon black as an efficient electrochemical sensor for sensitive detection of anti-COVID-19 drug Favipiravir in absence and presence of co-administered drug Paracetamol

Favipiravir (FVP) is introduced as a promising newly developed antiviral drug against the coronavirus disease 2019 (COVID-19). Therefore, the accurate determination of FVP is of great significance for quality assessment and clinical diagnosis. Herein, a novel electrochemical sensing platform for FVP based on gold nanoparticles anchored conductive carbon black (Au@CCB) modified graphite nanopowder flakes paste electrode (GNFPE) was constructed. Morphological and nanostructure properties of Au@CCB have been investigated by TEM, HRTEM, and EDX methods. The morphology and electrochemical properties of Au@CCB/GNFPE were characterized by SEM, cyclic voltammetry (CV), and EIS. The Au@CCB nanostructured modified GNFPE exhibited strong electro-catalytic ability towards the oxidation of FVP. The performance of the fabricated Au@CCB/GNFPE was examined by monitoring FVP concentrations in the absence and presence of co-administered drug paracetamol (PCT) by AdS-SWV. It was demonstrated that the proposed sensor exhibited superior sensitivity, stability, and anti-interference capability for the detection of FVP. The simultaneous determination of a binary mixture containing FVP and the co-administered drug PCT using Au@CCB/GNFPE sensor is reported for the first time. Under optimized conditions, the developed sensor exhibited sensitive voltammetric responses to FVP and PCT with low detection limits of 7.5 nM and 4.3 nM, respectively. The sensing electrode was successfully used to determine FVP and PCT simultaneously in spiked human plasma and pharmaceutical preparations, and the findings were satisfactory. Finally, the fabricated sensor exhibited high sensitivity for simultaneous detection of FVP and PCT in the presence of ascorbic acid in a real sample.

Using nanostructured carbon black-based electrochemical (bio)sensors for pharmaceutical and biomedical analyses: A comprehensive review

The outstanding electronic properties of carbon black (CB) and its economic advantages have fueled its application as nanostructured electrode material for the development of new electrochemical sensors and biosensors. CB-based electrochemical sensing devices have been found to exhibit high surface area, fast charge transfer kinetics, and excellent functionalization. In the present work, we set forth a comprehensive review of the recent advances made in the development and application of CB-based electrochemical devices for pharmaceutical and biomedical analyses - from quantitative monitoring of drug formulations to clinical diagnoses - and the underlying challenges and constraints that need to be overcome. We also present a thorough discussion about the strategies and techniques employed in the development of new electrochemical sensing platforms and in the enhancement of their analytical properties and biocompatibility for anchoring active biomolecules, as well as the combination of these sensing devices with other materials aiming at boosting the performance and efficiency of the sensors.

Nanomaterial-based electrochemical sensors and biosensors for the detection of pharmaceutical compounds

The surging growth of the pharmaceutical industry is a result of the rapidly increasing human population, which has inevitably led to new biomedical and environmental issues. Aside from the quality control of pharmaceutical production and drug delivery, there is an urgent need for precise, sensitive, portable, and cost-effective technologies to track patient overdosing and to monitor ambient water sources and wastewater for pharmaceutical pollutants. The development of advanced nanomaterial-based electrochemical sensors and biosensors for the detection of pharmaceutical compounds has garnered immense attention due to their advantages, such as high sensitivity and selectivity, real-time monitoring, and ease of use. This review article surveys state-of-the-art nanomaterials-based electrochemical sensors and biosensors for the detection and quantification of six classes of significant pharmaceutical compounds, including anti-inflammatory, anti-depressant, anti-bacterial, anti-viral, anti-fungal, and anti-cancer drugs. Important factors such as sensor/analyte interactions, design rationale, fabrication, characterization, sensitivity, and selectivity are discussed. Strategies for the development of high-performance electrochemical sensors and biosensors tailored toward specific pharmaceuticals are highlighted to provide readers and scientists with an extensive toolbox for the detection of a wide range of pharmaceuticals. Our aims are two-fold: (i) to inspire readers by further elucidating the properties and functionalities of existing nanomaterials for the detection of pharmaceuticals; and (ii) to provide examples of the potential opportunities that these devices have for the advanced sensing of pharmaceutical compounds toward safeguarding human health and ecosystems on a global scale.

A novel megestrol acetate electrochemical sensor based on conducting functionalized acetylene black-CeO2NPs nanohybrids decorated glassy carbon microspheres

For the first time, megestrol acetate (MGA), a synthetic progestin with therapeutic use in breast cancer, is electrochemically studied to propose a new electroanalytical alternative for its detection in real samples. In the present work, a novel electrochemical sensor based on functionalized acetylene black-CeO₂NPs nanohybrids modified glassy carbon microspheres paste electrode (FAB-CeO₂NPs/GCMPE) was successfully fabricated and used for sensitive determination of MGA. The modified electrode has been characterized using scanning electron microscope (SEM), cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). The electrocatalytic reduction of MGA using FAB-CeO₂NPs/GCMPE was carried out via CV and square wave voltammetry (SWV). By employing FAB-CeO₂NPs/GCMPE, the SWV signal of MGA reduction was 8 fold higher than the bare GCMPE. A wide concentration range from 4.20 × 10^-8 to 1.13 × 10^-6 M with the low LOD of 1.30 nM for MGA was achieved. The practical analytical utilities of the prospective FAB-CeO₂NPs/GCMPE sensor were demonstrated successfully by the detection of MGA in Megace tablets, human serum and urine samples obtained from healthy and patient volunteers after oral administration of 160 mg Megace tablets. HPLC method was also developed for comparison with the electroanalytical method.